Crovalimab, Crovalimab
BO42354
Phase 3 small_molecule active
Quick answer
Crovalimab, Crovalimab for Atypical Hemolytic Uremic Syndrome (aHUS) is a Phase 3 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active